Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010
GlobalData, July 2010, Pages: 81
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010
Summary
Our “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010” report is an essential source of data and trend analysis on the mergers and acquisitions (M&A) and financings in the medical equipment market. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered in the medical equipment industry in Q2 2010. The report portrays detailed comparative data on the number of deals and their value in the last five quarters subdivided by deal types, segments, and geographies. Additionally, the report provides information on the top private equity, venture capital, and advisory firms in the medical equipment industry.
Data presented in this report is derived from Our proprietary in-house Medical eTrack deals database and primary and secondary research.
Scope
- Analyze market trends for the medical equipment/medical devices market in the global arena
- Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
- Summary of medical equipment deals globally in the last five quarters
- Information on the top deals that took place in the medical equipment market
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
- Review the financial metrics, such as operating profit ratio, P/E ratio, and EV/EBITDA on mergers and acquisitions
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner
- Find out the major deal performing segments for investments in your industry
- Evaluate type of companies divesting / acquiring and ways to raise capital in the market
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the medical equipment market
- Identify major private equity/venture capital firms that are providing finance in the medical equipment market
- Identify growth segments and opportunities in each region within the industry
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry
- Identify top deals makers in the medical equipment market
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Medical Equipment, Deal Summary
2.1 Medical Equipment, Global Deals Analysis, Q2 2010
2.2 Medical Equipment, Global Number of Deals by Type, Q2 2010
2.3 Medical Equipment, Global Top Deals, Q2 2010
3 Medical Equipment, Top Deal Makers, Q2 2010
4 Medical Equipment, Deal Summary, By Type
4.1 Medical Equipment, Global Merger and Acquisition Deals, Q2 2010
4.1.1 Top M&A Deals in Q2 2010
4.2 Medical Equipment, Global Equity Offering Deals, Q2 2010
4.2.1 Top Secondary Offerings in Q2 2010
4.2.2 Top PIPE Deals in Q2 2010
4.3 Medical Equipment, Global Debt Offering Deals, Q2 2010
4.3.1 Top Public Debt Offerings in Q2 2010
4.3.2 Top Private Debt Placements in Q2 2010
4.4 Medical Equipment, Global Venture Capital Deals, Q2 2010
4.5 Medical Equipment, Global Top Venture Financing Firms, Last One Year
4.5.1 Top Venture Financing Deals in Q2 2010
4.6 Medical Equipment, Global Private Equity Deals, Q2 2010
4.7 Medical Equipment, Global Partnership Deals, Q2 2010
4.7.1 Partnership Deals in Q2 2010
5 Medical Equipment, M&A Financial Analysis
5.1 Medical Equipment, Global Acquisitions, Average Deal Value versus Median Deal Value,
Q2 2009 - Q2 2010
5.2 Medical Equipment, Global Acquisitions, Average Price Earnings of Acquired Companies,
Q2 2009 - Q2 2010
5.3 Medical Equipment, Global Acquisitions, Average EV/EBITDA of Acquired Companies,
Q2 2009 - Q2 2010
5.4 Medical Equipment, Global Acquisitions, Average Deal Value per Operating Profit,
Q2 2009 - Q2 2010
5.5 Medical Equipment, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q2 2009 - Q2 2010
5.6 Medical Equipment, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q2 2009 - Q2 2010
5.7 Medical Equipment, Global Acquisitions, Average Deal Value Per Sales, Q2 2009 - Q2 2010
6 Medical Equipment, Deal Summary, By Market
6.1 Global In Vitro Diagnostics Deals, Q2 2010
6.1.1 In-Vitro Diagnostics -Deals of the Quarter
6.2 Global Healthcare IT Deals, Q2 2010
6.2.1 Healthcare IT - Deals of the Quarter
6.3 Global Cardiovascular Devices Deals, Q2 2010
6.3.1 Cardiovascular Devices - Deals of the Quarter
6.4 Global Surgical Equipment Deals, Q2 2010
6.4.1 Surgical Equipment -Deals of the Quarter
6.5 Global Diagnostic Imaging Deals, Q2 2010
6.5.1 Diagnostic Imaging -Deals of the Quarter
6.6 Global Orthopedic Devices, Deals, Q2 2010
6.6.1 Orthopedic Devices - Deals of the Quarter
6.7 Global Anesthesia and Respiratory Devices, Deals, Q2 2010
6.7.1 Anesthesia and Respiratory Devices -Deals of the Quarter
6.8 Global Drug Delivery Devices, Deals, Q2 2010
6.8.1 Drug Delivery Devices - Deals of the Quarter
6.9 Global Hospital Supplies Deals, Q2 2010
6.9.1 Hospital Supplies -Deals of the Quarter
6.10 Global Patient Monitoring Deals, Q2 2010
6.10.1 Patient Monitoring - Deals of the Quarter
6.11 Global Wound Care Management Deals, Q2 2010
6.11.1 Wound Care Management - Deals of the Quarter
6.12 Global Nephrology and Urology Devices Deals, Q2 2010
6.12.1 Nephrology and Urology Devices - Deals of the Quarter
6.13 Global Dental Devices Deals, Q2 2010
6.13.1 Dental Devices -Deals of the Quarter
6.14 Global Ophthalmic Devices’ Deals, Q2 2010
6.14.1 Ophthalmic Devices - Deals of the Quarter
6.15 Global Diabetes Care Devices Deals, Q2 2010
6.15.1 Diabetes Care Devices - Deals of the Quarter
6.16 Global Endoscopy Devices Deals, Q2 2010
6.16.1 Endoscopy Devices- Deals of the Quarter
6.17 Global Neurology Devices Deals, Q2 2010
6.17.1 Neurology Devices - Deals of the Quarter
6.18 Global Ear, Nose and Throat Devices Deals, Q2 2010
6.18.1 ENT Devices - Deals of the Quarter
7 Medical Equipment, Deal Summary, By Geography
7.1 Medical Equipment, North America Region Deals, Q2 2010
7.1.1 North America - Deals of the Quarter
7.2 Medical Equipment, European Region Deals, Q2 2010
7.2.1 Europe - Deals of the Quarter
7.3 Medical Equipment, Asia-Pacific Region Deals, Q2 2010
7.3.1 Asia-Pacific - Deals of the Quarter
7.4 Medical Equipment, Rest of the World Deals, Q2 2010
7.4.1 Rest of the World - Deals of the Quarter
8 Medical Equipment, Top Advisors
8.1 Medical Equipment, Global Top Financial Advisors, Mergers and Acquisitions, Last One Year
8.2 Medical Equipment, Global Top Financial Advisors, Equity Offerings, Deal Summary, Last One Year
8.3 Medical Equipment, Global Top Financial Advisors, Debt Offerings, Deal Summary, Last One Year
9 Appendix
10 Further Information
10.1 Methodology
10.2 About Us
10.3 Contact Us
10.4 Disclosure information
10.5 Disclaimer
Medical Equipment Quarterly Deals Analysis M&A and Investments Trends - Q2 2010
“Medical Equipment Quarterly Deals Analysis M&A and Investments Trends - Q2 2010” report is an essential source of data and trend analysis on the Mergers and Acquisitions (M&A) and financing in the medical equipment market. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Q2 2010. The report portrays detailed comparative data on the number of deals and their value in the last five quarters subdivided by deal types, segments, and geographies. Additionally, the report provides information on the top private equity, venture capital and advisory firms in the medical equipment industry.
Data presented in this report is derived from the proprietary in-house Medical eTrack deals database and primary and secondary research.
M&A Activity Decreased In The Medical Equipment Industry In Q2 2010
M&As and asset transactions, which include change in ownership and control of companies or assets (the authors consider this value as not a new investment into the market), witnessed a huge decrease in deal value from $39.8 billion in Q1 2010 to $8.5 billion in Q2 2010. Further the number of deals also decreased from 110 deals in Q1 2010 to 78 deals in Q2 2010. The huge deal value in Q1 2010 was due to the landmark deal of Novartis’ agreement to acquire an additional 52% stake in Alcon for $28.1 billion.
In terms of the number of deals, the most active buyers were Essilor International with 14 M&A deals, followed by Covidien plc with eight M&A deals.
The average P/E (price earnings ratio) of acquired medical equipment companies, which reflects the willingness of investors to pay for a company’s earnings, decreased from 25 times in Q1 2010 to 10 times in Q2 2010, which signifies that companies are not anticipating short term growth prospects for a return on investments in the medical equipment industry. The average deal value decreased from $738 million in Q1 2010 to $128 million in Q2 2010, and the median deal value also decreased to $32 million in Q2 2010 from $40 million in Q1 2010. The abnormal increase in the average deal value in Q1 2010 was due to Novartis and Merck’s separate acquisition deals worth $35.1 billion.
The authors expect that M&A activity will be on a rising trend as the demand for medical devices has the potential to go high with increasing ageing population. The slow stabilization of the economy will also lead to an increase in M&A activity in the coming years.
According to Bhaskar Vittal “M&A activity is likely to remain subdued for the rest of 2010 due to the economic uncertainties in some of the European economies and slow growth in the US. Availability of finance becomes difficult during economic uncertainty leading to low M&A activity. Also companies will be cautious in their approach to inorganic growth during these periods.”
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
